Results of Regional Hyperthermic Perfusion for Primary and Recurrent Melanomas of the Extremities

  • P.-E. Jönsson
  • L. Hafström
  • A. Hugander
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 86)

Abstract

The technique for regional isolated perfusion has remained essentially the same since it was introduced in 1957, with the exception that heat was added in 1967 (Creech et al. 1958; Stehlin 1969). The anticancer drug most consistently used since 1957 is melphalan (Alkeran). The aim of isolation perfusion is to subject the tumor-bearing region to the influence of a high concentration of anticancer drugs in such a way that contamination of other parts of the body does not occur to any significant extent (Stehlin 1969). Malignant melanoma of the extremities seems especially suitable for this treatment, because local and regional metastases occur in up to 20% of patients (McBride et al. 1975). Reports of prolonged survival and local control of tumor growth have also encouraged many centers to perform this kind of treatment, not only for palliative (therapeutic) but also for curative (adjuvant) purposes (McBride et al. 1975; Stehlin et al. 1975; Martijn et al. 1982). In this report the experience with, and results of, hyperthermic melphalan perfusion for primary and recurrent melanoma in Lund since 1976 are presented.

Keywords

Oncol Melphalan Actinomycin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cox KR (1974) Survival after amputation for recurrent melanoma. Surg Gynecol Obstet 139: 720PubMedGoogle Scholar
  2. Creech O Jr, Krementz ET, Ryan RF, Winblad JN (1958) Regional perfusion utilizing an extracorporeal circuit. Ann Surg 148: 616PubMedCrossRefGoogle Scholar
  3. Day CL, Sober AJ, Kopf A, Lew RA, Mihm MC (1981) A prognostic model for clinical stage I melanoma of the lower extremity. Surgery 89: 599PubMedGoogle Scholar
  4. Fortner JG, Strong EW, Mulcare RJ, Schottenfield D, Maclean BJ (1974) The surgical treatment of recurrent melanoma. Surg Clin North Am 54: 865PubMedGoogle Scholar
  5. Hafström L, Jönsson P-E (1979) Regional perfusion with anticancer drugs for treatment of malignant tumors. In: Pettersson HI (ed) Tumor blood circulation CRC, Florida, p 217Google Scholar
  6. Hafström L, Jönsson P-E (1980) Hyperthermic perfusion of recurrent melanoma on the extremities. Acta Chir Scand 146: 313PubMedGoogle Scholar
  7. Karakousis CP, Kanter PM, Lopez RE, Moore R, Holyoke ED (1979) Modes of regional chemotherapy. J Surg Res 26: 134PubMedCrossRefGoogle Scholar
  8. Krementz ET, Carter RD, Sutherland CM, Campell M (1979) The use of regional chemotherapy in the management of malignant melanoma. World J Surg 3: 289PubMedCrossRefGoogle Scholar
  9. Lejeune FJ, Mathieu M, Kenis Y (1977) Hyperthermic isolation perfusion with melphalan. A preliminary appraisal of local and general effects in malignant melanoma. Tumori 63: 289PubMedGoogle Scholar
  10. Martijn H, Oldhoff J, Schraffordt-Koops H (1982) Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities. J Surg Oncol 20: 9PubMedCrossRefGoogle Scholar
  11. McBride CM, Sugarbaker EV, Hickey RC (1975) Prophylactic isolation perfusion as the primary therapy for massive malignant melanoma of the limbs. Ann Surg 182: 316PubMedCrossRefGoogle Scholar
  12. Schraffordt-Koops H, Oldhoff J, van der Ploeg E, Vermey A, Eiberger R (1977) Regional perfusion for recurrent melanoma of the extremities. Am J Surg 133: 221PubMedCrossRefGoogle Scholar
  13. Stehlin JS Jr (1969) Hyperthermic perfusion with chemotherapy for cancer of the extremities. Surg Gynecol Obstet 129: 305PubMedGoogle Scholar
  14. Stehlin JS Jr, Giovanella BC, de Ipolyi PP, Muenez LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140: 338Google Scholar
  15. Sugarbaker EV, McBride CM (1976) Survival and regional disease control after isolation perfusion for massive stage I melanoma of the extremities. Cancer 37: 188PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1983

Authors and Affiliations

  • P.-E. Jönsson
    • 1
  • L. Hafström
    • 1
  • A. Hugander
    • 1
  1. 1.Department of SurgeryUniversity of LundLundSweden

Personalised recommendations